Tech Company Inital Public Offerings
Harpoon Therapeutics IPO
Harpoon Therapeutics, operating out of San Francisco, had an IPO event on 2/8/2019.
Transaction Overview
Company Name
Announced On
2/8/2019
Transaction Type
IPO
Amount
$75,600,000
Proceeds Purpose
Proceeds will be used as follows: approximately $67.0 million to fund the clinical development of HPN424 (our PSMA-targeting TriTAC) through our Phase 1 trial and into a Phase 2 trial and HPN536 (our MSLN-targeting TriTAC) through our planned Phase 1/2a trial; and the remaining proceeds to fund the development of our pipeline, including HPN217 (our BCMA-targeting TriTAC), our DLL3-Targeting TriTAC, our ProTriTAC programs and our discovery programs, and for other general corporate purposes, which may include the hiring of additional personnel, capital expenditures and the costs of operating as a public company.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
131 Oyster Point Blvd. 300
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Harpoon Therapeutics (Nasdaq: HARP) is an immuno-oncology company developing a novel class of T cell engagers that unleash the natural power of the T cells to fight cancer and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerald McMahon
Chief Financial Officer
Georgia Erbez
Chief Medical Officer
Natalie Sacks
Chief Scientific Officer
Holger Wesche
Vice President
Che-Leung Law
VP - Bus. Development
Rachael Lester
VP - Finance
Christopher Whitmore
VP - Product Management
Susan Jones
Browse more venture capital transactions:
Prev: 2/8/2019: GOAT venture capital transaction
Next: 2/8/2019: Green Dot Bioplastics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs